Raymond James & Associates’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
DSA
BHG
LAM
LBA
GC
Raymond James & Associates's ADNT Position: Q3 2019 in Review
Raymond James & Associates sold out of Adient (ADNT) in Q3 2019, closing a stake of 8,580 shares — an estimated $208K sold.
Raymond James & Associates first reported a position in ADNT in Q4 2016 and held it in 9 quarters. The position peaked at $11.7M in Q4 2017. 307 funds tracked by Wall St. Rank hold ADNT as of Q3 2019.
- Raymond James & Associates reported no remaining Adient position as of Q3 2019 after selling out during the quarter.
- Raymond James & Associates sold 8,580 Adient shares in Q3 2019, an estimated $208K.
- Raymond James & Associates first reported a position in Adient in Q4 2016 and held it in 9 quarters.
- Raymond James & Associates's Adient position peaked at $11.7M in Q4 2017.
- 307 funds tracked by Wall St. Rank held Adient as of Q3 2019.
Based on Raymond James & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.